DAILY CARE & SPECIAL CARE
READY TO MARKET COMPLETE PROBIOTICS SOLUTIONS
ABOUT US IN NUMBERS
30
Years of experience in probiotics
55
Exporting to countries
47
Probiotics Researchers (PhD, MS)
214
R&D achievements
#1
Korean probiotics exporter
Probiotics Market, Korea FDA, 2013-2023
#1
in the Singapore probiotics market
ETC Category, Singapore Market, IQVIA, 2022
#2
in the Denmark probiotics market
Probiotics Market, DLiMi Data, 2023
#1
in the Indonesian probiotics market
Probiotics, Sachet categoy, ITMA MAT Q3 2023
DUOLAC® DENMARK
YOUR JOURNEY TO A HEALTHIER, HAPPIER LIFE
OUR KEY FEATURES
30 YEARS EXPERIENCE
PROBIOTICS SPECIALIST ONE STOP SOLUTION
Since its foundation by microbiologists in 1995, we have over 3 decades of experience in the pharmaceutical industry and are ready to provide a full service to our partners with personalized, innovative, scientifically documented probiotic solutions and marketing services.
EXPERIENCE OUR
TOP-QUALITY
FDA GRAS
NOTIFIED STRAINS
Obtaining GRAS notification from the U.S. FDA involves a rigorous evaluation process, requiring numerous scientific data and evidence demonstrating the safety of a sub stance for its intended use in food products.
With 11 strains, Cell Biotech has obtained GRAS notification, positioning itself as the global leader with the highest number of probiotics recognized for GRAS status. This milestone affirms the safety of Cell Biotech's probiotics in the worldwide market.
WORLDWIDE PATENTED COATING TECHNOLOGY
CLINICALLY PROVEN
100 TIMES HIGHER SURVIVAL RATE
Our dual-coated probiotics show a remarkable 100 times higher survival rate in the intestines compared to uncoated probiotics, as confirmed by fecal analysis. This means a significantly greater number of beneficial bacteria reach their intended destination, ensuring optimal effectiveness.
YOUR TRUST WORTHY PARTNER
ONE STOP PROBIOTICS OEM/ODM SOLUTION
With over 30 years of experience in probiotics, we offer a complete OEM/ODM service tailored to meet the diverse needs of our global clients. From raw materials to finished products, we provide rigorously researched, safe strains that adhere to the highest global quality standards. Partner with us to unlock the full potential of probiotics and create products that resonate with consumers worldwide.
PP-P8 PROTEIN & DDS
ANTI-COLORECTAL CANCER
TREATMENT
We proudly announces the approval of the Phase I clinical trial plan (IND) for our groundbreaking colorectal cancer drug, 'PP-P8', by the Ministry of Food and Drug Safety. PP-P8 represents a pioneering advancement in microbiome-based therapeutics, harnessing the power of Korean-derived probiotics.
WHOLE GENOME SEQUENCING
UNLOCKING THE GENETIC POTENTIAL
We prioritize safety and transparency in our probiotic products through comprehensive Whole Genome Sequencing (WGS).
This cutting-edge technology allows us to analyze the entire genetic makeup of our strains,
ensuring a thorough understanding of their characteristics and functions.
DISCOVER MORE ABOUT US
STRAIN
MANAGEMENT
IN-HOUSE
FERMENTATION
